Trial intelligence / Profile preview

rhTPO in ITP in Pregnancy

NCT02270801Phase 3Unknown

Sponsor
Shandong University
Start
Oct 2014
Primary completion
Jan 2017
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 3 trial of recombinant human thrombopoietin in immune thrombocytopenia (ITP), sponsored by Shandong University. Status: unknown.

02

Drugs

recombinant human thrombopoietin
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on NCT02270801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02270801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call